Eosinophilic myositis as presenting symptom in γ-sarcoglycanopathy

Neuromuscular Disorders

Volumn 19, Issue 2, 2009, Pages 167-171

  Baumeister, Sarah K ^a   Todorovic, Slobodanka ^b   Milić Rašić, Vedrana ^b   Dekomien, Gabriele ^c   Lochmüller, Hanns ^d   Walter, Maggie C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Sarcoglycanopathy; Eosinophilic myositis; LGMD2C; Limb girdle muscular dystrophy

Indexed keywords

CALCIUM; COLECALCIFEROL; CORTICOSTEROID; GAMMA SARCOGLYCAN; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG WITHDRAWAL; EOSINOPHIL MYOSITIS; EXTENSOR MUSCLE; FACE MUSCLE; FEMALE; FLEXOR MUSCLE; FOOT; FOREARM; GAIT DISORDER; GAMMA SARCOGLYCANOPATHY; GASTROCNEMIUS MUSCLE; GENETIC ANALYSIS; HAND MUSCLE; HIP; HUMAN; HUMAN TISSUE; KNEE; LEG MUSCLE; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE BIOPSY; MUSCLE HYPERTROPHY; MUSCLE WEAKNESS; MYOPATHY; MYOSITIS; NECK MUSCLE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RECESSIVE INHERITANCE; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VASTUS LATERALIS MUSCLE;

ANTI-INFLAMMATORY AGENTS; BIOPSY; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; EOSINOPHILIA; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MUSCLE FIBERS, SKELETAL; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MYOSITIS; PREDNISOLONE; SARCOGLYCANS; SERBIA; YOUNG ADULT;

EID: 59249092358     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.11.010     Document Type: Article

References (16)

1. Norwood F., deVisser M., Eymard B., Lochmüller H., and Bushby K. EFNS Guideline Task Force. EFNS guideline on diagnosis and management of limb girdle muscular dystrophies. Eur J Neurol 14 12 (2007) 1305-1312
2. Serratrice G., Pellissier J.F., Roux H., and Quilichini P. Fasciitis, perimyositis, myositis, polymyositis and eosinophilia. Muscle Nerve 13 (1990) 385-395
3. Krahn M., Lopez de Munain A., Streichenberger N., et al. CAPN3 mutations in patients with idiopathic eosinophilic myositis. Ann Neurol 59 6 (2006) 905-911
4. Brown Jr. R.H., and Amato A. Calpainopathy and eosinophilic myositis. Ann Neurol 59 (2006) 875-877
5. Amato A.A. Adults with eosinophilic myositis and calpain-3 mutations. Neurology 70 9 (2008) 730-731 Feb 26
6. Weinstock A., Green C., Cohen B.H., and Prayson R.A. Becker muscular dystrophy presenting as eosinophilic inflammatory myopathy in an infant. J Child Neurol 12 2 (1997) 146-147
7. Guyon J.R., Kudryashova E., Potts A., et al. Calpain 3 cleaves filamin c and regulates its ability to interact with gama- and delta-sarcoglycans. Muscle Nerve 28 (2003) 472-483
8. Arahata K., Ishihara T., Fukunaga H., et al. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve 2 (1995) 56-66
9. Pegoraro E., Mancias P., Swerdlow S.H., et al. Congenital muscular dystrophy with primary laminin alpha 2 (merosin) deficiency presenting as inflammatory myopathy. Ann Neurol 40 5 (1996) 782-791
10. Rowin J., Meriggioli M.N., Cochran E.J., and Sanders D.B. Prominent inflammatory changes on muscle biopsy in patients with Myoshi myopathy. Neuromuscul Disord 9 6-7 (1999) 417-420
11. McNally E., Ly C.T., Rosenmann H., et al. Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am J Med Gen 91 (2000) 305-312
12. Gallardo E., Rojas-Garcia R., de Luna N., Pou A., Brown Jr. R.H., and Illa I. Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology 57 11 (2001) 2136-2138 Dec 11
13. Godfrey C., Escolar D., Brockington M., et al. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Ann Neurol 60 (2006) 603-610
14. Darin N., Kroksmark A.K., Ahlander A.C., Moslemi A.R., Oldfors A., and Tulinius M. Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I. Eur J Ped Neurol 11 6 (2007) 353-357
15. Biancheri R., Falace A., Tessa A., et al. POMT2 gene mutation in limb-girdle muscular dystrophy with inflammatory changes. Biochem Biophys Res Commun 363 4 (2007) 1033-1037 Nov 30
16. Cai B., Spencer M.J., Nakamura G., Tseng-Ong L., and Tidball J.G. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. Am J Pathol 156 5 (2000) 1789-1796